Literature DB >> 15016873

High-throughput screening of the yeast kinome: identification of human serine/threonine protein kinases that phosphorylate the hepatitis C virus NS5A protein.

Carlos Coito1, Deborah L Diamond, Petra Neddermann, Marcus J Korth, Michael G Katze.   

Abstract

The hepatitis C virus NS5A protein plays a critical role in virus replication, conferring interferon resistance to the virus through perturbation of multiple intracellular signaling pathways. Since NS5A is a phosphoprotein, it is of considerable interest to understand the role of phosphorylation in NS5A function. In this report, we investigated the phosphorylation of NS5A by taking advantage of 119 glutathione S-transferase-tagged protein kinases purified from Saccharomyces cerevisiae to perform a global screening of yeast kinases capable of phosphorylating NS5A in vitro. A database BLAST search was subsequently performed by using the sequences of the yeast kinases that phosphorylated NS5A in order to identify human kinases with the highest sequence homologies. Subsequent in vitro kinase assays and phosphopeptide mapping studies confirmed that several of the homologous human protein kinases were capable of phosphorylating NS5A. In vivo phosphopeptide mapping revealed phosphopeptides common to those generated in vitro by AKT, p70S6K, MEK1, and MKK6, suggesting that these kinases may phosphorylate NS5A in mammalian cells. Significantly, rapamycin, an inhibitor commonly used to investigate the mTOR/p70S6K pathway, reduced the in vivo phosphorylation of specific NS5A phosphopeptides, strongly suggesting that p70S6 kinase and potentially related members of this group phosphorylate NS5A inside the cell. Curiously, certain of these kinases also play a major role in mRNA translation and antiapoptotic pathways, some of which are already known to be regulated by NS5A. The findings presented here demonstrate the use of high-throughput screening of the yeast kinome to facilitate the major task of identifying human NS5A protein kinases for further characterization of phosphorylation events in vivo. Our results suggest that this novel approach may be generally applicable to the screening of other protein biochemical activities by mechanistic class.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016873      PMCID: PMC371080          DOI: 10.1128/jvi.78.7.3502-3513.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  A biochemical genomics approach for identifying genes by the activity of their products.

Authors:  M R Martzen; S M McCraith; S L Spinelli; F M Torres; S Fields; E J Grayhack; E M Phizicky
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

2.  4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase.

Authors:  S R von Manteuffel; A C Gingras; X F Ming; N Sonenberg; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

Review 3.  The protein kinases of budding yeast: six score and more.

Authors:  T Hunter; G D Plowman
Journal:  Trends Biochem Sci       Date:  1997-01       Impact factor: 13.807

4.  Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo.

Authors:  K Deacon; J L Blank
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  A papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transcription but is defective in transformation and plasmid retention.

Authors:  C W Lehman; D S King; M R Botchan
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A.

Authors:  Y Tanji; T Kaneko; S Satoh; K Shimotohno
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

7.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

Authors:  N Enomoto; I Sakuma; Y Asahina; M Kurosaki; T Murakami; C Yamamoto; Y Ogura; N Izumi; F Marumo; C Sato
Journal:  N Engl J Med       Date:  1996-01-11       Impact factor: 91.245

Review 8.  Pathobiologic effects of hepatitis C.

Authors:  M A Gerber
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

9.  Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase.

Authors:  K E Reed; J Xu; C M Rice
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

10.  Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.

Authors:  N Enomoto; I Sakuma; Y Asahina; M Kurosaki; T Murakami; C Yamamoto; N Izumi; F Marumo; C Sato
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more
  23 in total

1.  Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication.

Authors:  Petra Mannová; Laura Beretta
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 2.  Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants.

Authors:  Eu Jin Lim; Ruth Chin; Peter W Angus; Joseph Torresi
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

3.  Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy.

Authors:  He Huang; Rongyan Kang; Ji Wang; Guangxiang Luo; Wei Yang; Zhendong Zhao
Journal:  Autophagy       Date:  2012-11-20       Impact factor: 16.016

4.  TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

Authors:  D G Cordek; J T Bechtel; A T Maynard; W M Kazmierski; C E Cameron
Journal:  Drugs Future       Date:  2011-09       Impact factor: 0.148

Review 5.  Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Authors:  Alberto Grassi; Giorgio Ballardini
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

6.  CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.

Authors:  Makoto Yamamoto; Hiroshi Onogi; Isao Kii; Suguru Yoshida; Kei Iida; Hiroyuki Sakai; Minako Abe; Toshiaki Tsubota; Nobutoshi Ito; Takamitsu Hosoya; Masatoshi Hagiwara
Journal:  J Clin Invest       Date:  2014-07-08       Impact factor: 14.808

7.  Serine 229 Balances the Hepatitis C Virus Nonstructural Protein NS5A between Hypo- and Hyperphosphorylated States.

Authors:  Chia-Ni Tsai; Ting-Chun Pan; Cho-Han Chiang; Chun-Chiao Yu; Shih-Han Su; Ming-Jiun Yu
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

8.  Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription.

Authors:  Andrew Street; Andrew Macdonald; Christopher McCormick; Mark Harris
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

9.  Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication.

Authors:  Matthew J Evans; Charles M Rice; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

10.  Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain.

Authors:  Nicole Appel; Thomas Pietschmann; Ralf Bartenschlager
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.